Get all your news in one place.
100's of premium titles.
One app.
Start reading
LiveScience
LiveScience
Sneha Khedkar

MYSTERIOUS: Drug could reduce need for insulin in type 1 diabetes early trial hints | Mind Blowing Facts

Young woman doing insulin injection pen, close-up. Gecko Studio via Shutterstock.

A drug commonly used to treat the autoimmune disease  rheumatoid arthritis (RA) could also slow the progression of type 1 diabetes, an early clinical trial suggests. 

Similar to RA, type 1 diabetes is an autoimmune condition — in RA, the body's immune cells attack the joints, while in diabetes, they destroy insulin-producing beta cells in the pancreas. The resulting insulin deficiency means cells can't remove glucose from the bloodstream, causing blood sugar to skyrocket. Treating type 1 diabetes requires daily insulin injections. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.